4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000073
Chief Medical Officer sold 4,091 shares at $34.17 ($139,789)
- Chief Medical Officer acquired 8,374 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,374 | 65,362 | D | ||
| 2025-07-01 | Sale : show line 2 in the form 10b5-1 | −4,091 | $34.17 | $139,789 | 61,271 | D |
| Open-market sales · 4,091 sh · avg $34.17 · $139,789 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-01 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −8,374 | 8,375 | D |
Loading xslF345X05/wk-form4_1751572884.xml…